✦ LIBER ✦

IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells

✍ Scribed by Cheryl M. Sweeney; Roisin Lonergan; Sharee A. Basdeo; Katie Kinsella; Lara S. Dungan; Sarah C. Higgins; Patrick J. Kelly; Lisa Costelloe; Niall Tubridy; Kingston H.G. Mills; Jean M. Fletcher

Book ID: 116277140
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 601 KB
Volume: 25
Category: Article
ISSN: 0889-1591
DOI: 10.1016/j.bbi.2011.03.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon beta inhibits the Th17 cell-m

Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing–remitting multiple sclerosis

✍ Xin Zhang; Silva Markovic-Plese 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 214 KB

CS4-4 Cell type-specific responses to IF

CS4-4 Cell type-specific responses to IFN-β: Implications for understanding the mechanism of IFN-β therapy in multiple sclerosis

✍ Anette H.H. van Boxel-Dezaire; Elizabeth Fisher; Richard M. Ransohoff; Richard A 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Th17 cells are restrained by Treg cells

Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti–tumor necrosis factor antibody therapy

✍ Jenny L. McGovern; Dao X. Nguyen; Clare A. Notley; Claudia Mauri; David A. Isenb 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB